Drug Shortage Report for LABETALOL HYDROCHLORIDE INJECTION, USP
Report ID | 10718 |
Drug Identification Number | 02387468 |
Brand name | LABETALOL HYDROCHLORIDE INJECTION, USP |
Common or Proper name | LABETALOL HYDROCHLORIDE INJECTION, USP |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | LABETALOL HYDROCHLORIDE |
Strength(s) | 5MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 20ML 1VL |
ATC code | C07AG |
ATC description | BETA BLOCKING AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2017-05-01 |
Actual start date | 2018-05-05 |
Estimated end date | Unknown |
Actual end date | 2019-03-08 |
Shortage status | Resolved |
Updated date | 2019-03-09 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-05-19 | English | Compare |
v2 | 2017-05-19 | English | Compare |
v3 | 2017-05-19 | French | Compare |
v4 | 2017-06-11 | English | Compare |
v5 | 2017-07-07 | English | Compare |
v6 | 2017-07-07 | English | Compare |
v7 | 2017-07-07 | English | Compare |
v8 | 2017-07-07 | French | Compare |
v9 | 2017-07-08 | English | Compare |
v10 | 2017-07-18 | English | Compare |
v11 | 2017-07-18 | French | Compare |
v12 | 2017-07-25 | English | Compare |
v13 | 2017-07-25 | French | Compare |
v14 | 2017-08-01 | English | Compare |
v15 | 2017-08-01 | French | Compare |
v16 | 2017-08-15 | English | Compare |
v17 | 2017-08-15 | French | Compare |
v18 | 2017-12-04 | English | Compare |
v19 | 2017-12-04 | French | Compare |
v20 | 2018-02-02 | English | Compare |